Water absorption of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

Percentage change in the apparent density of pristine and modified Egyptian kaolin sintered at 1050 °C for 4 successive cycles. by Nasser A. M. Barakat (11705885)

Porosity of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

XRD pattern for the prepared silicon oxide nanoparticles. by Nasser A. M. Barakat (11705885)

Summary of nanostructured additives used in this study, including type, morphology, dimensions, and source or preparation method. by Nasser A. M. Barakat (11705885)

SEM images showing the microstructure of pristine kaolin. by Nasser A. M. Barakat (11705885)

Thermal gravimetric analyses and the first derivative for the obtained data for the CNTs; (A and B), AC; (C and D) and SiO₂; (E and F) compared with the pristine kaolin. by Nasser A. M. Barakat (11705885)

Effect of each additive on Kaolin ceramic properties at different sintering temperatures. by Nasser A. M. Barakat (11705885)

Model A: Logistic structural model. by Abigail A. Lee (19935335)

“…Additionally, higher income slightly predicted decreased HPV vaccine hesitancy. All other latent variables and covariates were not significantly predictive of intent to vaccinate in the overall structural mode. …”

Forest plots illustrate the mean difference in; (A) hospital stay, (B) ICU stay, (C) intubation time; with subgroup analysis. by Mohamed R. Abdelraouf (21501468)

Co-Contraction index of right and left gluteus medius activity (MVC%) during 60 minutes standing (time- condition) between two groups (A: used the footrest intermittently, B: used... by Saeedeh Abbasi (9423189)

Decomposition analysis of gastric cancer burden in Taiwan, stratified by gender. (A) Incidence. (B) Prevalence. (C) Mortality. (D) DALYs. Positive values on the X-axis indicate an... by Xiaohuang Yang (10182727)

Primers used for PCR and qRTPCR. by Huan W. Yang (19746645)

“…<i>intracellularis</i> infection. In this study, we investigated the nuclear factor-<b>κ</b>B (NF-κB)-regulated immune response against infection of a clinical strain Dkp23 and a live-attenuated Enterisol vaccine strain in PK-15 cells. …”

Western blots used for Fig 4C. by Huan W. Yang (19746645)

“…<i>intracellularis</i> infection. In this study, we investigated the nuclear factor-<b>κ</b>B (NF-κB)-regulated immune response against infection of a clinical strain Dkp23 and a live-attenuated Enterisol vaccine strain in PK-15 cells. …”

Magnification x2 of Fig 1B. by Huan W. Yang (19746645)

“…<i>intracellularis</i> infection. In this study, we investigated the nuclear factor-<b>κ</b>B (NF-κB)-regulated immune response against infection of a clinical strain Dkp23 and a live-attenuated Enterisol vaccine strain in PK-15 cells. …”

Cyclosporin A significantly reduces the survival rate and completely inhibits the formation of multicellular aggregates in tolerant strains under caspofungin stress. by Yongqin Wu (272012)

“…<p>(A) Cyclosporin A decreases the survival rate of tolerant strains under caspofungin. …”

Graphical representation of surface roughness values on the specimen surface after tests conducted at different time intervals (a) Ra, Rq (b) Rz (c) Sa, Sq (d) Sz, Sp, Sv. by Yang Li (7082)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”